A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
Trending
- MTN suspends xtratime over new FCCPC rules
- UN backs Nigeria lead solutions, highlights digital tools
- NDA promotes officers, urges greater commitment
- NOA urges women to nurture children, defend rights
- ActionAid urges review of revenue deductions
- Abiodun inaugurates 5.5km Abeokuta road
- Stakeholders push investment in Nigeria’s agribusiness
- UNILAG medicine faculty targets clinical innovation
